Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer–Specific Mortality in a Large Nationwide Cohort

Shu‐Fen Liao, Jill Koshiol, Yi‐Hsiang Huang, Sarah S. Jackson, Yu‐Han Huang, Chi Chan, Claire Huang, Po‐Chun Liu, Yen‐Ju Chen, Rebecca J. Hsieh, Ching‐Po Huang, Sheng‐Nan Lu, Chien‐Jen Chen, Chen‐Yang Shen, Mei‐Hsuan Lee – 2 May 2021

DNA Methylation Markers for Detection of Cholangiocarcinoma: Discovery, Validation, and Clinical Testing in Biliary Brushings and Plasma

Ju Dong Yang, Hassan Ghoz, Mohammed M. Aboelsoud, William R. Taylor, Tracy C. Yab, Calise K. Berger, Xiaoming Cao, Patrick H. Foote, Nasra H. Giama, Emily G. Barr Fritcher, Douglas W. Mahoney, Catherine D. Moser, Thomas C. Smyrk, Benjamin R. Kipp, Gregory J. Gores, Lewis R. Roberts, John B. Kisiel – 2 May 2021 – Cholangiocarcinoma (CCA) has poor prognosis due to late‐stage, symptomatic presentation. Altered DNA methylation markers may improve diagnosis of CCA.

Hepatic Small Ubiquitin‐Related Modifier (SUMO)–Specific Protease 2 Controls Systemic Metabolism Through SUMOylation‐Dependent Regulation of Liver–Adipose Tissue Crosstalk

Yang Liu, Xin Dou, Wei‐yu Zhou, Meng Ding, Ling Liu, Ruo‐qi Du, Liang Guo, Shu‐wen Qian, Yan Tang, Qi‐qi Yang, Dong‐ning Pan, Xiao‐ying Li, Yan Lu, Jin‐ke Cheng, Qi‐qun Tang – 1 May 2021

Subscribe to